PrimaryCareNOW: A Pri-Med Virtual Conference | Pri-Med

Thank you to all who joined us live for PrimaryCareNOW on Thursday–Friday, March 18–19, 2021. If you were not able to join us live, some sessions have been recorded and are available below. 

Upcoming Virtual Conferences 
Please join us for next month’s PrimaryCareNOW on Thursday–Friday, April 15–16. 
Pri-Med has more virtual education planned. View our upcoming programs.  


  CME/CE Accredited Session

Non-CME/CE Session
Sponsored by Industry

Click For Session Details
Session Times Listed in ET

8–9am ET    CME/CE Accredited Session



A case of a woman with early symptoms of joint pains is presented and discussed as to what clinical, laboratory, imaging, and physical features will guide us to identify and distinguish between RA, psoriatic arthritis, SLE, and fibromyalgia.  The key historical and clinical findings that distinguish these diseases are presented and the proper interpretation of imaging and tests like the ANA are reviewed.

Peng Thim Fan, MD, FACP

Clinical Professor of Medicine, Division of Rheumatology, David Geffen School of Medicine at UCLA, Los Angeles, CA

9:10–10:10am ET    CME/CE Accredited Session


When Statins Alone Won’t Do: A Primary Care Playbook for Navigating the New Frontier of Non-Statin LDL-C-Lowering Adjuncts and Alternatives

Joyce Ross, MSN, CRNP, CLS, FNLA, FPCNA | James A. Underberg, MS, MD, FACP, FNLA


Statins are widely used for reducing low-density lipoprotein cholesterol (LDL-C) and lowering atherosclerotic cardiovascular disease (ASCVD) risk. However, residual ASCVD risk in statin-treated patients is prevalent. Among the drivers of increased risk is persistent LDL-C elevation due to statin-associated side effects, which often lead to statin discontinuation or under-dosing. A survey of primary care practitioners revealed that recognizing residual risk and statin intolerance might be impediments to managing cholesterol levels in their patients. In-depth knowledge about the available and emerging non-statin adjunctive and alternative therapies, as well as understanding the guidance from national organizations about when they should be implemented, is the key to improving patient care. 


Clinical Associate, University of Pennsylvania School of Nursing, Consultant and Speaker, Cardiovascular Risk Intervention

James A. Underberg, MS, MD, FACP, FNLA

Clinical Assistant Professory of Medicine, NYU School of Medicine & NYU Center for Prevention of Cardiovascular Disease, Director, Bellevue Hospital Lipid Clinic, Past President National Lipid Association, President, American Board Clinical Lipidology

Supported by Esperion Therapeutics, Inc.

10:20–11:05am ET    Non-CME Industry Theater


Victor Howard, MD, FACC


  • Recognize the health burden and prevalence of CKD
  • Understand CKD risk factors and the progressive nature of renal function decline
  • Identify the risk of CKD in patients with T2D
  • Review screening and monitoring recommendations in CKD
  • Highlight current approaches to the management of CKD

Victor Howard, MD, FACC

Senior Medical Director, Cardiovascular US Medical Affairs, AstraZeneca

Dr. Howard was born in Charleston, West Virginia and is the second eldest of five siblings. His family moved to Texas at an early age, but ultimately all transitioned to Florida. He received his Bachelor of Science undergraduate degree and medical degree from the University of Miami with AΩA honors. He completed his residency in Internal Medicine at Parkland Hospital/University of Texas Southwestern Medical School in Dallas, Texas. He completed his fellowship in cardiology at the Methodist Hospital/Texas Medical Ctr. Baylor College of Medicine in Houston, Texas.

He returned to Florida to practice general and interventional cardiology on the southwest coast of Florida for over 28 years. After a few years in a multispecialty practice he transitioned to building the largest single specialty practice in the state of Florida based in Sarasota. During that time he developed a highly regarded cardiology practice, but also was extensively involved in education, external consultation, and participation in over 60 clinical research trials. In March, 2014 he transitioned to a field medical directorship in the cardiovascular division of medical affairs at Astra Zeneca. His primary responsibility is to provide scientific and clinical expertise with respect to brand medical strategy as well as to develop enhanced peer relationships with physicians and institutions in the cardiovascular arena. His involvement extends to areas such as investigator sponsored research, support of clinical trials and major conferences/advisory boards and education.

He resides in Sarasota, Florida with his wife Tiffany and three children Nathan, Nick, and Sophia. He enjoys the symphony, opera, and theater as well as spending time with his family whether it be relaxing on the beach or hiking and skiing in the mountains.

Sponsored by AstraZeneca

10:20–11:05am ET    Non-CME Industry Theater


Rethinking the Role of Nebulization in the Maintenance Treatment of COPD

Aaron P. Milstone, MD, FCCP


Join us to learn about the first and only once-daily nebulized LAMA for the maintenance treatment of COPD

Aaron P. Milstone, MD, FCCP

Medical Director, Williamson Pulmonary and Sleep Medicine, Williamson Medical Group, Franklin, TN, Former Associate Professor and Medical Director of Vanderbilt’s Lung Transplant Program

Sponsored by Viatris and Theravance Biopharma

11:15am–12:15pm ET    CME/CE Accredited Session

Hot Topics


Practice-changing updates to the medical literature that are hot off the presses! Join Dr. Pam Kushner to discuss important changes in the 2021 ADA guidelines and examine recently published research on atrial fibrillation, lipids, reducing cardiovascular risk, coconut oil, patient communication, and much more!

Pamela Kushner, MD, FAAFP

Clinical Professor, University of California Irvine Medical Center, Director, Kushner Wellness Center, Los Alamitos, CA

12:25–1:10pm ET    Non-CME Industry Theater


Case Study: A 51-Year-Old Female With Crohn’s Disease and Intestinal Resection*

Ann Michalek, MD


*This is a hypothetical case and not an actual patient    


Uncover the cause of the patient's symptoms in this virtual case study and consider if this could apply to any patients you manage

Ann Michalek, MD

Associate Professor of Clinical Medicine,
Albany Medical Center,
Delmar, NY

Sponsored by Takeda Pharmaceuticals U.S.A., Inc.

12:25–1:10pm ET    Non-CME Industry Theater


GLP-1 RA – Moving the Needle for Injectable Therapies for Adult Patients With T2D

Pablo Mora, MD, FACE, MS Sc, CDE


Evaluate when the guidelines recommend GLP-1 RA use for T2D treatment. Review the glucose-dependent mechanism of action, safety, and dosing of a once-weekly GLP-1 RA.  Discuss the efficacy and safety data from pivotal T2D glycemic control trials and from the cardiovascular outcomes trial

Pablo Mora, MD, FACE, MS Sc, CDE

Endocrinologist, North Texas Diabetes Center in Plano (Texas), Clinical Professor of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas,

Sponsored by Novo Nordisk Inc.

1:20–2:20pm ET    CME/CE Accredited Session

Hot Topics


Learn the impact of health disparities in communities of color. This presentation highlights the factors that contribute to health inequalities for Black, Hispanic and Native American communities.  This includes a discussion of how social determinants of health has specifically impacted COVID-19. We will review racism as a social determinant of health and discuss how a historical perspective can provide further context into health disparities of communities of color. Implicit bias has been shown to play a role in health disparities.  We will discuss strategies to help overcome implicit bias including perspective taking, cultural humility, and workforce diversity.  Lastly, we’ll discuss how wellness can help achieve health equity.

Nicola Finley, MD

Internal Medicine and Integrative Medicine Physician, Tucson, AZ

2:30–3:30pm ET    CME/CE Accredited Session


Top Questions I Get Asked About: Migraine, Movement Disorders, and Dizziness/Vertigo  

Patricia E. Greenstein, MB.BCh | Rashmi B. Halker Singh, MD, FAHS, FAAN | Daniel Press, MD


What do primary care providers need to know about migraine, movement disorders, dizziness, and vertigo? Join neurologists Patricia Greenstein, Daniel Press, and Rashmi Halker Singh as they review important questions they get asked about these topics!

Patricia E. Greenstein, MB.BCh

Assistant Professor, Harvard Medical School, Associate Director, BIDMC Neurology Residency Training Program, Director, Neurogenetics Clinic, Beth Israel Deaconess Medical Center, Boston, MA

Rashmi B. Halker Singh, MD, FAHS, FAAN

Associate Professor of Neurology, Director, Headache Medicine Fellowship Program, Division of Headache Medicine, Department of Neurology, Mayo Clinic, Scottsdale, AZ

Daniel Press, MD

Associate Professor of Neurology, Harvard Medical School, Chief, Cognitive Neurology Unit, Clinical Director, Berenson-Allen Center for Noninvaisve Brain Stimulation, Beth Israel Deaconess Medical Center, Boston, MA

3:40–4:25pm ET    Non-CME Industry Theater


Exploring the Proposed Mechanism Behind Delusions and Hallucinations in Dementia-Related Psychosis

Stephen A. Brunton, MD, FAAFP


This program will provide general information regarding dementia-related hallucinations and delusions and will discuss a proposed neural pathway that may be associated with them. Additionally, the unmet need for the treatment of dementia-related hallucinations and delusions will be discussed, with a particular focus on the risk/benefit ratio of current atypical antipsychotics. This disease awareness, non-CME presentation is intended only for US healthcare professionals involved in the management of people with dementia-related hallucinations and delusions and is sponsored by Acadia Pharmaceuticals Inc. This program is not meant to discuss specific treatment options for dementia-related psychosis. 

Stephen A. Brunton, MD, FAAFP

Executive Vice President for Education, Primary Care Education Consortium, Winnsboro, SC

Dr. Brunton is an Adjunct Clinical Professor in the department of Family Medicine at the University of North Carolina (UNC), Chapel Hill. Concomitantly, he serves as the Executive Vice President for Education for the Primary Care Education Consortium (PCEC), along with Executive Director of Primary Care Metabolic Group (PCMG) and Editor-in-Chief of Clinical Diabetes at the Primary Care Metabolic Group (ADA Primary Care Journal)

Sponsored by ACADIA Pharmaceuticals Inc.

8–9am ET    CME/CE Accredited Session


"My Belly Hurts and I’m Having Bowel Problems": Stepping Up Treatment of Irritable Bowel Syndrome and Chronic Idiopathic Constipation

Philip Schoenfeld, MD, MSEd, MSc


This activity will provide an evidence-based approach to the diagnosis and management of irritable bowel syndrome (IBS) and chronic idiopathic constipation (CIC), with minimal diagnostic testing. The faculty will describe evidence-based treatment guidelines and discuss the efficacy of over-the-counter and prescription agents prioritized within the guidelines. This will help you navigate the progress from patient education to diet plus over-the-counter agents to prescription agents.

Philip Schoenfeld, MD, MSEd, MSc

Chief (Emeritus) - Gastroenterology Section, John D. Dingell VA Medical Center, Detroit, MI

Supported by Allergan and Ironwood Pharmaceuticals, Inc. Salix Pharmaceuticals, Inc.

9:10–10:10am ET    CME/CE Accredited Session

Infectious Disease

Managing Influenza: Practical Strategies For Primary Care

Paul E. Sax, MD | Charles Vega, MD, FAAFP


This session on influenza diagnosis and management will improve how you respond when annual fluctuations in vaccine efficacy expose your patients to risk of serious illness. Through interactive patient cases, the faculty will demonstrate how to identify and treat patients with suspected influenza, including patients at high risk for complications. These practical, evidence-based strategies will help you to use antiviral medications effectively and reduce the burden of influenza.

Paul E. Sax, MD

Clinical Director, Division of Infectious Diseases, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School, Boston, MA

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, Executive Director, UC Irvine Program in Medical Education for the Latino Community, UC Irvine School of Medicine, Irvine, CA

Supported by an educational grant from Genentech, a member of the Roche Group

10:20–11:05am ET    Non-CME Industry Theater


Uncontrolled Asthma: Changing the Patient Experience

Neil Skolnik, MD


This session will use a case presentation to discuss the impact of uncontrolled asthma and tools for assessing asthma control as well as asthma management. Learn to identify ways to customize management of uncontrolled asthma by exploring medication options for appropriate patients.

Neil Skolnik, MD

Neil Skolnik, MD

Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health

Sponsored by GlaxoSmithKline

11:15am–12:15pm ET    CME/CE Accredited Session



Colorectal cancer is the third most common cause of cancer and the third leading cause of cancer death in men and women in the U.S. However, it is a highly preventable disease. During this talk, Dr. Kimmie Ng will review the epidemiology of colorectal cancer and the basics of colorectal cancer screening. She will present the different options available for screening, the evidence supporting each method, and current recommended screening guidelines. She will also discuss the diet and lifestyle factors that may have a role in the primary prevention of colorectal cancer. Finally, she will present data about the alarming rise of colorectal cancer in young people under the age of 50 and discuss hypotheses about the underlying causes and future research directions.

Kimmie Ng, MD, MPH

Associate Professor of Medicine at Harvard Medical School, Director, Young-Onset Colorectal Cancer Center, Co-Director, Colon and Rectal Cancer Center, Director of Translational Research, Center for Gastrointestinal Oncology, Dana-Farber Cancer Institute, Boston, MA

12:25–1:10pm ET    Non-CME Industry Theater


Piecing it Together: Completing the Patient Picture to Identify Hidradenitis Suppurativa (HS) and Support Patient Care

Lindsay S. Ackerman, MD


  • Understand the chronic, progressive, and immune-mediated nature of HS by exploring a potential patient journey
  • Identify clinical signs and symptoms of HS for both adolescents and adults and the impact of timely diagnosis
  • Partner with a dermatologist for appropriate treatment when HS is suspected

Lindsay S. Ackerman, MD

Founder, Medical Dermatology Specialists, Attending Teaching Faculty, Banner – University Medical Center Phoenix, Clinical Assistant Professor, Dermatology, Banner University of AZ College of Medicine, Phoenix, Arizona

Lindsay S. Ackerman, MD, was the founding physician of Medical Dermatology Specialists in Phoenix, Arizona. She currently serves as Attending Teaching Staff for Dermatology at Banner – University Medical Center Phoenix in Arizona, and as a Clinical Assistant Professor for U of A College of Medicine, Phoenix. She earned her medical degree at the University of Arizona College of Medicine in Tucson and completed an internship in Combined Medicine/Pediatrics at Banner Good Samaritan Medical Center followed by a residency in Dermatology at Tulane University in New Orleans, Louisiana, and a fellowship in Complex Medical Dermatology at Tulane University. Dr. Ackerman is board certified in Dermatology. She remains an active educator of dermatology to primary care residents in the Phoenix area., , Dr. Ackerman has served as a Delegate for the AAD to the American Medical Association since 2005, and has been active in local, national and international dermatology societies. Dr. Ackerman has been published in several peer-reviewed publications, including JAMA Dermatology and JAAD, and has been invited to share her independent research at international meetings such as the World Congress on Gender Medicine, European Academy of Dermatology and Venereology, and the World Congress of Dermatology.

Sponsored by AbbVie

12:25–1:10pm ET    Non-CME Industry Theater


Close to the Heart: The Importance of Recognizing Cardiovascular Risk in Type 2 Diabetes

John E. Anderson, MD


The objective of this program is to communicate the importance of addressing cardiovascular risk in patients with type 2 diabetes. The program will cover data on prevalence, morbidity, mortality, and intensive versus conventional glucose lowering on macrovascular complications. In addition, the program will review guidance from leading medical associations that is based upon completed cardiovascular outcome trials of antihyperglycemic medications in patients with type 2 diabetes.

John E. Anderson, MD

Internal Medicine and Diabetes, The Frist Clinic, Nashville, TN

Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC

1:20–4:50pm ET    CME/CE Accredited Session


Strategies for Effective Pain Management

Charles E. Argoff, MD, FABPM | Oscar A. de Leon-Casasola, MD | Katherine E. Galluzzi, DO, CMD, FACOFP


The nation is facing competing public health issues: the need to treat a large number of Americans with acute and chronic pain versus the crisis of prescription opioid abuse. Pri-Med’s Strategies for Effective Pain Management curriculum focuses on improving practitioners’ ability to recognize, diagnose, and classify pain; educating clinicians on the full spectrum of pain management options, including non-opioid pharmacologic interventions; and providing risk reduction strategies through integration of opioids into individualized pain management plans. Clinicians will learn to recognize signs and symptoms of opioid dependence and abuse to manage patients’ pain and medication use optimally.

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA). 

Charles E. Argoff, MD, FABPM

Professor of Neurology, Albany Medical College, Director, Comprehensive Pain Center, Albany Medical Center, Albany, NY

Oscar A. de Leon-Casasola, MD

Professor of Anesthesiology and Medicine, Senior Vice-Chair, The Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, Chief, Pain Medicine and Professor of Oncology, Roswell Park Cancer Institute, Buffalo, NY

Katherine E. Galluzzi, DO, CMD, FACOFP

Professor and Chair, Department of Geriatrics, Philadelphia College of Osteopathic Medicine, Philadelphia, PA

Supported by Opioid Analgesic REMS Program Companies

5–5:45pm ET    Non-CME Industry Theater


Managing Insomnia in Patients with Mild to Moderate Alzheimer's Disease

Jerald Simmons, MD


  • Understand the burden of insomnia in insomnia patients with mild to moderate Alzheimer's disease
  • Review the profile of an insomnia patient with mild to moderate Alzheimer's disease
  • Review an option to help manage insomnia

Jerald Simmons, MD

Dr. Jerald H Simmons completed medical school at Ohio State University and completed a residency in Neurology at Washington University, Barnes Hospital, and St. Louis, MO. Dr. Simmons completed a fellowship in Sleep Disorder Medicine at Stanford University Medical Center and a second fellowship in epilepsy at UC Davis. Dr. Simmons is board certified in the areas of Neurology, Sleep and Epilepsy. Dr. Simmons is founding director at Comprehensive Sleep Medicine Associates and REST Technologies, Inc. Dr. Simmons is also published in various journals on sleep disorders.

Sponsored by Merck